Fennec Pharmaceuticals Inc. (FRX:TSX) closed at $13.62 on October 15, 2026, down 5.87% on the day. The stock trades 22.8% below its 52-week high of $17.64 and 79.4% above its 52-week low of $7.59. Over the past year, it gained 11.3%. Fennec Pharmaceuticals Inc. is part of the Life Sciences sector (Biotechnology).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -6.00% | -7.47% | -7.03% | +51.33% | +11.27% |
In 252 trading sessions since October 15, 2025, FRX closed higher on 74 days (29%). Its best day was May 14, 2026 (+36.31%) and its worst was March 24, 2026 (-18.62%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 13 times.
Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities.
Find more stocks like FRX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.